Abstract
Objective
Acute and chronic forms of myocarditis are mainly induced by virus infections. As a consequence of myocardial damage and inflammation dilated cardiomyopathy and chronic heart failure may develop. The gold standard for the diagnosis of myocarditis is endomyocardial biopsies which are required to determine the etiopathogenesis of cardiac inflammatory processes. However, new non-invasive MRI techniques hold great potential in visualizing cardiac non-ischemic inflammatory lesions at high spatial resolution, which could improve the investigation of the pathophysiology of viral myocarditis.
Results
Here we present the discovery of a novel endogenous T2* MRI contrast of myocardial lesions in murine models of acute and chronic CVB3 myocarditis. The evaluation of infected hearts ex vivo and in vivo by 3D T2w and T2*w MRI allowed direct localization of virus-induced myocardial lesions without any MRI tracer or contrast agent. T2*w weighted MRI is able to detect both small cardiac lesions of acute myocarditis and larger necrotic areas at later stages of chronic myocarditis, which was confirmed by spatial correlation of MRI hypointensity in myocardium with myocardial lesions histologically. Additional in vivo and ex vivo MRI analysis proved that the contrast mechanism was due to a strong paramagnetic tissue alteration in the vicinity of myocardial lesions, effectively pointing towards iron deposits as the primary contributor of contrast. The evaluation of the biological origin of the MR contrast by specific histological staining and transmission electron microscopy revealed that impaired iron metabolism primarily in mitochondria caused iron deposits within necrotic myocytes, which induces strong magnetic susceptibility in myocardial lesions and results in strong T2* contrast.
Conclusion
This T2*w MRI technique provides a fast and sensitive diagnostic tool to determine the patterns and the severity of acute and chronic enteroviral myocarditis and the precise localization of tissue damage free of MR contrast agents.
Introduction
Viral myocarditis is a major cause of heart failure and sudden death in young adults [1–3]. The gold standard for the diagnosis of viral myocarditis relies on endomyocardial biopsies, the only aetiopathogenic approach with, however, limited sampling coverage of the heart [4,5]. Cardiac MRI detects necrotic or fibrotic lesions in acute and chronic myocarditis using late gadolinium enhancement (LGE) T1 weighted contrast technique [6]. This non-invasive technique still requires contrast agent injection and dynamic MR image acquisition.
The pathogenesis and the underlying molecular mechanisms of acute and chronic myocarditis and resulting dilated cardiomyopathy have been mostly studied in animal studies [7]. In particular, coxsackievirus B3 (CVB3)-induced chronic myocarditis in susceptible mice such as ABY/J and SWR/J strains are most important mouse models reflecting very well different stages of viral myocarditis in patients [8]. However, only recently the first applications of cardiac MRI have been presented in this model in order to improve the non-invasive diagnosis of viral myocarditis. Brunner et al. [9] used cine MRI to measure alterations of cardiac function parameters. Jacoby et al. [10] and Ye et al. [11] demonstrated imaging of macrophage infiltration by using 19F fluorine MRI tracers in experimental myocarditis models.
In this work, we pursue to improve the non-invasive diagnosis of myocarditis by MRI techniques in the murine model of acute and chronic CVB3 myocarditis and report on the discovery of an unexpected endogenous MRI contrast using standard T2* weighted MRI. The evaluation of this contrast allowed a direct localization of virus-induced cardiac lesions without any MRI tracer or contrast agents, and thus to correlate the outcome and severity of myocarditis. Additional MR image analysis and histopathological investigations were performed in order to identify the mechanisms of the reported MR contrast and its biological origins. Finally, we report on the difficulty of using an iron oxide based contrast agent, ferumoxytol, to visualize inflammatory lesions in this animal model of CVB3-induced myocarditis.
Material and methods
Virus and animals
All procedures and animal studies were approved by the Regierungspräsidium Tübingen (permission no. PA1/08). Four-week-old mice from two mouse strains (SWR/J (H-2q) and ABY/SnJ (H-2b)) were infected with CVB3 Nancy strain as described previously [12,13]. Non-infected animals of both strains served as controls. For ex vivo MRI and histology, hearts were taken and perfused with PBS to remove blood from myocardium in order to avoid residual blood causing signal voids on ex vivo T2 and T2* weighted images. The hearts were fixed in 4% buffered formaldehyde for one day and further preserved in PBS at 4°C. Experimental groups of CVB3-infected ABY/SnJ and SWR/J mice (n = 3–6 per group) were used for ex vivo or in vivo MRI measurements at different time points post infection (p.i.) (6 days, 9 days for acute myocarditis, 14 days for sub-acute myocarditis and eight weeks and more for chronic myocarditis). Table 1 summarizes the different groups of animals investigated by MRI and histology with exact number of animals per group. The rationale driving the number of animals per group was the following: in this animal model of myocarditis the exact microscopic patterns of lesions are well known. There are only three groups of morphological findings: (no: not-infected control mice(H1), mild (H2) and severe myocarditis (H3)) we see at any time point post infection. With 5 infected animals per group we always observe animals with mild and severe myocarditis in each group at all time points post infection. Thus, each of these 3 groups forms an entity regarding the comparison of MRI findings with histology.
Table 1. Animal assignments and comparisons of MR and histology for all sets of animals investigated.
Animal Set | Time After Infection | Mouse strain | In vivo Ex vivo | MR1 | MR2 | MR3 | |
---|---|---|---|---|---|---|---|
A | Chronic | SWR/J | in vivo | H1 | 0 | 0 | 0 |
2–10 months | H2 | 0 | 0 | 0 | |||
Pre study | H3 | 0 | 0 | 3 | |||
Animals selected | ex vivo | H1 | 0 | 0 | 0 | ||
from larger group for | H2 | 0 | 0 | 0 | |||
strong T2* abnormalities | H3 | 0 | 0 | 2 | |||
B | Chronic | SWR/J | in vivo | H1 | 2c | 0 | 0 |
15 weeks | H2 | 2 | 1 | 0 | |||
H3 | 0 | 0 | 1 | ||||
C | Chronic | ABY | in vivo | H1 | 3c | 0 | 0 |
8 weeks | H2 | 1 | 1 | 0 | |||
H3 | 0 | 0 | 3 | ||||
ex vivo | H1 | 2c | 0 | 0 | |||
subset from | H2 | 1 | 1 | 0 | |||
in vivo | H3 | 0 | 0 | 3 | |||
D | Acute | ABY | in vivo | H1 | 0 | 0 | 0 |
14 days | H2 | 2 | 3 | 0 | |||
H3 | 0 | 0 | 3 | ||||
E | Acute | ABY | ex vivo | H1 | 0 | 0 | 0 |
14 days | H2 | 0 | 3 | 0 | |||
H3 | 0 | 0 | 2 | ||||
F | 9 days | SWR/J | ex vivo | H1 | 2c | 0 | 0 |
H2 | 1 | 1 | 0 | ||||
H3 | 0 | 0 | 1 | ||||
G * | 9 days | ABY | ex vivo | H1 | 0 | 0 | 0 |
H2 | 0 | 1 | 0 | ||||
H3 | 0 | 0 | 4 | ||||
H | 6 days | SWJ | ex vivo | H1 | 0 | 0 | 0 |
H2 | 2 | 2 | 0 | ||||
H3 | 0 | 0 | 0 | ||||
I | 6 days | ABY | ex vivo | H1 | 0 | 0 | 0 |
F+G+H+I inoculated | H2 | 2 | 3 | 0 | |||
at same time | H3 | 0 | 0 | 1 |
* one animal was excluded. It was giving strong abnormal contrast ex vivo but not in histology. The analysis revealed a technical error in histological workup. The abbreviations MR1, MR2 and MR3 are used to designate the 3 defined MR groups: MR1 no myocarditis, MR2 mild myocarditis and MR3 severe myocarditis. The abbreviation H1, H2 and H3 are used to define the histological groups no myocarditis (H1, observed only in control animals), mild myocarditis (H2) and severe myocarditis (H3). We observed non-zero values only along the diagonals in the case of severe myocarditis, meaning that no mismatch between histology and MR diagnostic in animals with severe myocarditis was found. Note that some animals with a mild myocarditis are not detected by MRI (animals on off-diagonal) due to the higher sensitivity of histology which is capable of detecting myocyte damage at the single cell level compared to MRI. Those animals represent always cases with little numbers of very small lesions. Numbers followed by letter c indicate non-infected control mice.
In order to investigate whether superparamagetic iron-oxide nanoparticles can be used for the visualization of immune cells (macrophages) in the heart of CVB3-infected mice by MRI, animals were subjected to tail vein injections of a 10 or 40 mg Fe/kg ferumoxytol (Feraheme, AMAG Pharmaceuticals, Lexington, MA) 12 days p.i. Two days after the ferumoxytol injection, the animals were remeasured by MRI and hearts were later investigated by histology.
Magnetic resonance imaging
Ex vivo MRI at high magnetic field
Ex vivo 3D T2w (7 hours acquisition, 50x100x100 μm voxel size) and T2*w (with 100 μm isotropic resolution) were acquired on a vertical Bruker AMX 500 microscopy system at 11.7 T with a maximum gradient strength of 660 mT/m using a 500.15 MHz 1H transceive quadrature birdcage resonator (RAPID Biomedical, Germany). Commercially available 3D spin echo and 3D spoiled multi-gradient echo sequences (Paravision 4.0 software) were used. Additional parameters for T2* weighted images: Matrix size 128x100x100, repetition time TR = 400 ms, echo times TE [ms] = 3, 6.5, 10, 13.5, 17, 20.5, 24, and 27.5. Frequency encoding = 13.2 kHz, bandwidth = 591.8 Hz/voxel, radio-frequency selective pulse bandwidth = 2700 Hz, flip angle = 50°, total acquisition time was 6h40min using 6 averages. Spin echo sequence parameters: TR = 2.5 s, TE = 14 ms, acquisition time = 7 hours, frequency encoding bandwidth = 195.3 Hz/voxel, radio-frequency selective pulse bandwidth = 2.7 kHz. Moreover, additional hearts were imaged with an ultra-high resolution of 50 μm isotropic using the AMX-500 system and a spoiled gradient echo sequence (isotropic resolution) or a vertical Bruker Avance 17.6 T microscopy system with a maximum gradient strength of 1 T/m. A commercially available 15 mm birdcage resonator was used. Two infected hearts were finally measured with an ultra-high resolution of 20 μm at 17.6 T using a scroll coil [14] built in-house (S2 Movie). Additionally, ex vivo imaging was performed directly from hearts immersed in 4% buffered formaldehyde. A comparison of image contrast on hearts affected by severe myocarditis imaged in 4% formaldehyde solution or washed in PBS after fixation did not reveal any difference concerning the reported observed T2* hypointense signals.
In vivo MRI at high magnetic field
In vivo MRI was performed on non-infected control mice and non-contagious CVB3-infected mice from day 14 p.i. up to 10 months after CVB3 infection. Breath gated and ECG triggered multi-slice multiple spoiled gradient-echo short axis heart images were acquired on a preclinical Bruker Biospec 7 T scanner, using an 870 mT/m gradient system and a commercial transmit/receive quadrature birdcage coil with inner diameter 3.5 cm. Seven to eleven slices of images were acquired in single slice and/or interleaved multi-slice modus. Single slice images were acquired in addition to multi-slice images to increase image quality of slices of interest thanks to reduced sensitivity to blood flow artifact and increased contrast between myocardium and blood. Echo times were: 2.6 ms, 6 ms, 9.4 ms, 12.8 ms, 16.2 ms. FA = 60–80° when multislice acquisition with 7–11 slices, FA = 20° for single slice acquisition. Data were averaged 4–8 times but such as acquisition time would not exceed 20 min. Typical matrix size = 256x170 points, FOV = 3x2 cm, slice thickness = 0.5 mm. RF Pulse interval = heart period.
Ex vivo MRI investigation at clinical static magnetic field strength
Also, formalin-fixed hearts from ABY/SnJ mice with severe myocarditis obtained 9 days p.i. (as diagnosed using T2*w images at 7 T) were imaged ex vivo using the preclinical 17.6T system (TE = 16 ms) and a clinical 1.5T scanner (SIEMENS Avento, TE = 18 ms). Commercial 3D spoiled gradient echo sequences were used with imaging parameters as similar as possible between the two scanners. In particular, voxel size was 146 μm and bandwidth was 120 Hz/voxel.
Histology
Six 1 mm thick slices along the heart long axis obtained by using a tissue slicer were embedded in paraffin. Axial tissue sections (5 μm) were cut and stained with hematoxylin/eosin (HE) and Masson’s trichrome stain to assess myocardial injury, inflammation and fibrosis or with Prussian blue to assess iron deposits (Fe3+) as described previously [13]. In addition, calcification was examined by von Kossa staining. For the qualitative histological assessment of myocardial damage and definition of grades of myocarditis infection only sections distal to atria were considered. Infected animals with sections presenting very few or sparse small lesions were assigned a grade of mild myocarditis (H2). Animals with numerous lesions had severe myocarditis (H3). Animals without any visible lesions (observed in control animals only) were assigned the grade H1 (no lesion, i.e. non-infected control animals).
Electron microscopy
Heart tissue samples were fixed in 3% glutaraldehyde in 0.2 M phosphate buffer (pH 7.4) for 1 hour at room temperature. After three washes for 1 hour at room temperature in 0.2 M phosphate buffer, the tissue slices were fixed in 1% osmium tetroxide in the same buffer, dehydrated in a graded series of ethanol, blocked-stained with 1% uranylacecate and 1% phosphotungstic acid in 70% ethanol, further dehydrated and embedded in Araldite (Merck, Darmstadt, Germany). Ultrathin sections (70 nm) were cut with a diamond knife on an ultramicrotome and picked up on 300 mesh nickel grids. Sections were examined with a Zeiss EM 902 transmission electron microscope at a magnification of 5,000–30,000.
Identification of T2* hypointense signals in in vivo or ex vivo cardiac MRI
Images were analyzed by experienced researchers in the field of small rodents cardiac MRI and a radiologist. Care was taken to separate abnormal T2* hypointense signals from more common sources of signal losses in CMR images of mice induced for example by lung susceptibility inhomogeneity, blood flow, motion artifacts etc. To mitigate such artefacts, additional images were acquired in case of doubt on the presence or absence of abnormal T2* contrast. In case of ex vivo images, we qualified a T2* hypointense signal as abnormal, when it could not be associated with high confidence to air bubbles or remaining blood clots in heat chambers or large vessels. For clarity, we always write hypointense signals or dark spots to specifically refer to abnormal T2* signals only, reverting to the exact denomination only if requested by context. For all infected animals, investigators were blinded both at MR acquisition and at MR analysis since the degree of disease was unknown at scan time and during MR evaluation. Depending on the amount and size of the lesions observed by MRI, animals were assigned to one of the following 3 MR diagnostic groups: no myocarditis (no sign of abnormal T2* contrast, called MR1 grade), mild myocarditis (at least one well defined lesion in one slice, see examples in Fig 1 hearts 2 and 4), called MR2 grade or severe myocarditis, called MR3 grade (numerous lesions or at least one very large hypointense region, see Fig 1 hearts 3 and 5). After histological evaluation, the MR diagnostic was correlated with the histological reference.
Correlation of histological sections with 2D in vivo MR images
In this study, we performed a matching of in vivo MR images with the histological tissue sections, considering that the matching is only approximate due to the non-local nature of the T2* contrast, the non-continuous sectioning of the tissue slices as well as due to the differences in histological and MR slice thickness, in-plane resolution and orientation. Furthermore, tissue fixation and shrinking due to paraffin embedding and sectioning further influences the depiction between hearts imaged in vivo with MR and heart tissue as seen in histological sections.
Correlation of histological sections with 3D ex vivo MR images
For all investigated isolated hearts ex vivo, 3D MRI datasets as well as selected digitized histology slices (Masson’s trichrome and Prussian blue stained sections) were imported into the commercial 3D software Amira (FEI. Visualization Sciences Group, Burlington, MA, USA). Histological sections were displayed in a separate pane from the MRI data. After optimization of the MR image contrast between buffer and myocardium, the position and orientation of oblique slices within the 3D MR dataset were manually adjusted in order to give optimal visual matching between pathological as well as non-pathological structures observed with MRI and histology.
Results
Ex vivo T2* contrast study of acute myocarditis at high static magnetic field
Hearts of SWR/J and ABY/SnJ mice, both susceptible for chronic myocarditis were investigated at different time points after CVB3 infection by in vivo and ex vivo MRI, demonstrating comparable results. Our initial ex vivo MRI study at 11.7 T revealed an unexpected patchy T2* (TE = 3 ms) hypointense contrast of CVB3-infected myocardium in both mouse strains at any investigated time point p.i., which was not observed in uninfected hearts (Fig 1 heart 1). Typical areas with patchy hypointense T2* contrast during acute myocarditis (day 9 and 14 p.i.) are exemplarily shown in Fig 1, heart 2–5, long axis row A, short axis row B of ABY/SnJ mice. The frequency and localization of the observed T2* hypointense regions correlated well with virus-induced inflammatory lesions as detected by Masson's trichrome stainings obtained from the same regions of the hearts (Fig 1, row C). The different patterns of virus-induced myocardial lesions are well reflected by the T2*w MRI images, thus allowing in particular to visualize the outcome and severity of acute myocarditis. A typical example of mild myocarditis is shown in Fig 1, heart 4, and of severe myocarditis in Fig 1, heart 5, both day 14 p.i. The grade of myocarditis, as revealed by histology, is systematically compared to the MR diagnostic in Table 1.
Identifying the biological cause of hypointense regions in acute myocarditis
It is well known that pathological T2*w hypointense regions in MRI are suggestive for being paramagnetic. One well-defined atomic/molecular carrier of paramagnetic inhomogeneities is given by endogenous (super) paramagnetic iron deposits [15]. Recently, we have observed significant iron accumulations in infected myocytes from CVB3-induced cardiac lesions of susceptible SWR/J mice [13] during acute as well as chronic myocarditis.
In order to evaluate whether the hypointense regions in MRI are due to iron incorporation we stained consecutive tissue sections by HE, Masson's trichrome and Prussian blue for all investigated hearts. We noted that iron is present in acute and chronic myocarditis as early as day 6 p.i. in inflammatory lesions of SWR/J mice and also of ABY/SnJ mice. Fig 2A illustrates the close spatial correlation of hypointense regions in MRI T2*w images (A1 and A4) with inflammatory lesions (Masson's trichrome, A2 and A5) and iron (Prussian blue staining, A3 and A6) in the hearts of two ABY/SnJ mice demonstrated in Fig 1 (heart 2, day 9 p.i. (A4-6) and heart 4, day 14 p.i. (A1-3) respectively). The variability in the intensity of Prussian blue staining demonstrates different concentrations of iron in infected and necrotic myocytes, which are dependent on the stage and progress of virus-induced damage. However, independent to the amount of iron we find MRI hypointensity at all stages of myocarditis (see additional observations in section on additional MRI results). In order to exclude that fibrosis or calcification is responsible for hypointensity effects in MRI we stained consecutive tissue sections of mouse hearts with Masson's trichrome, HE, von Kossa and Prussian blue. As exemplarily shown in Fig 2B the area fraction of calcium precipitates (brown, B4) or collagen (blue, B1) present in cardiac lesions is very low compared to the extent of iron deposits (blue, B3) within inflammatory lesions (B2) in the heart obtained 14 days p.i. Thus, the close spatial relationship of iron positive areas with hypointensity areas in MRI at any stage of myocarditis provides firm evidence that iron is the decisive element in the detection of cardiac lesions in our mouse model by MRI. Blood (mircobleeds) as cause of iron deposition was excluded by our histological staining.
Evaluation of CVB3 infection by transmission electron microscopy
In order to evaluate iron deposition observed in Prussian blue staining in more detail we examined representative tissue samples of CVB3-infected murine hearts from ABY/SnJ mice by transmission electron microscopy in the course of infection. In contrast to non-infected control hearts (Fig 3A) we found electron dense deposits in myocytes at any stage of infection (Fig 3B–3D). As shown in Fig 3B, at 6 d p.i. small areas with electron dense material are primarily observed in mitochondria. Starting from day 9 p.i. there is a considerable increase in the amount of electron dense material in mitochondria (Fig 3C) primarily in the infected (arrow illustrates virions) and damaged myocytes. In the final stages of infection (Fig 3D, 28 days p.i.), the virus-induced necrotic myocyte (right side of image) contains plentiful electron dense deposits, consistent with iron. On the left side, an uninfected myocyte is demonstrated without any kind of deposits. Importantly, deposits were found to be consistently associated with structural alterations of mitochondria, namely of disruption of cristae and, in parallel with severe disturbances in the myocyte architecture. Infected myocytes (arrow points to virions) with many electron dense deposits revealed a severe loss of myofibrils in absence of normal mitochondria (Fig 3D, right side), reflecting necrosis typically observed in CVB3-infected mice as shown in Fig 1.
Ex vivo T2* contrast study of chronic myocarditis at high static magnetic field
In addition to hearts obtained during acute infection, mouse hearts of 8 weeks post infection up to several months after CVB3 infection were investigated by ex vivo T2*w MRI. As demonstrated in both ABY/J (Fig 4A, 8 weeks p.i.) and SWR/J mice (Fig 4B, 8 months p.i.), strong hypointense regions in myocardium were observed in MRI at late stages of myocarditis. The frequency and location of the T2* dark spots correlated very well with the grade of the CVB3-induced myocardial lesions (Fig 4A4 and 4B4). Prussian blue staining of myocardial lesions was generally strong (Fig 4A5 and 4B5), but appeared, as already seen during acute infection, sometimes inhomogeneous (Fig 4A5). As shown in cases with short echo times (Fig 4A2), the shape of the hypointense regions seem to follow the periphery of the cardiac lesions. This suggests that the T2* contrast ex vivo correlates well with the distribution of iron as identified within Prussian blue staining. Altogether, the findings in MRI revealing hypointense regions are rather similar in hearts with acute or chronic myocarditis.
T2* blooming demonstrates existence of strong local magnetic susceptibility inhomogeneities
On increasing echo time, the size of the reported hypointense regions increased in all recorded ex vivo T2*w gradient echo images and for all hearts where cardiac lesions were visible, as illustrated in Fig 4A2 (short TE), A3 (long TE), B2 (short TE), B3 (long TE) and in Fig 5F (short TE) and G (long TE). From a physical point of view, this so called “T2* blooming effect” indicates the presence of local magnetic susceptibility inhomogeneities in the vicinity of the cardiac lesions: local magnetic susceptibility inhomogeneities induce local static magnetic field variations which in turn result in dephasing of the transverse magnetization proportional to the strength of the magnetic field alteration and proportional to the echo time during a gradient echo experiment. This local dephasing of the transverse magnetization results in increased signal cancellation within magnitude images when echo time increases (Fig 4A2, 4A3, 4B2 and 4B3 and in Fig 5F and 5G) and in local phase variations within gradient echo phase images (see example of high pass filtered phase images of the T2* weighted 3D datasets in Fig 5H).
Ex vivo 3D spin echo images demonstrate that susceptibility inhomogeneities are paramagnetic
For all infected animals showing T2*w hypointense contrast for which additional spin echo 3D datasets had been recorded, a hypointense patchy contrast was visible (Figs 5B and 6A–6D), which correlated perfectly with the hypointense contrast observed in gradient echo images. The contrast observed in spin echo experiment was strong and visible at all echo times but no T2 blooming effect was present. See example in Fig 5B (short TE) and Fig 5C (long TE). Non-infected animals showed homogeneous myocardium in T2 and T2* images as illustrated in Fig 5A and 5E. The apparent size of the tissue lesions in spin echo images appeared smaller in spin echo images with TE = 10 ms (Fig 5B) than in gradient echo images with TE = 3 ms (Fig 5F). This result strongly supports the hypothesis that the observed hypointense T2 and T2* contrasts originate mainly from strong local susceptibility inhomogeneities.
To assess the cause of the susceptibility differences observed between lesions and healthy tissue, the frequency encoding of the spin-echo images was recorded with a relatively "low" voxel bandwidth of 190 Hz/voxel and the resulting ex vivo spin echo heart images compared to spin echo images of air bubbles placed in water and measured with the exact same imaging parameters. Small, isolated regions of altered magnetic susceptibility (isolated air bubble, isolated blood clot or isolated lesion) are expected to behave like small magnet dipoles, creating dipolar patterns in gradient echo phase images. Such dipole patterns are visible in Fig 5H for some tissue lesions and in trapped air/blood clot (Fig 5A, colored inset). Those dipoles induce in spin echo images a characteristic arrow-like pattern as observed in Fig 5D for the air bubble phantom and in Fig 5B for tissue lesions. Those arrow-like patterns do point in the same direction for air bubbles and for isolated cardiac lesions. These results demonstrate that the regions with altered magnetic susceptibility within infected myocardium are paramagnetic with respect to (fixed) healthy tissue (or water) [16,17]. The paramagnetic character of the local magnetic field inhomogeneities was observed ex vivo in spin-echo images for diseased animals during the chronic phase of myocarditis but at earlier times points of myocarditis as well (Fig 6). Qualitatively, the arrow-like paramagnetic contrast is already clearly visible as early as 9 d p.i. (Fig 6C), becomes strong at day 14 p.i. (Fig 6D) and remains very strong at all other chronic stages (Fig 6E and 6F).
In correlation with the first histological indications of cardiac lesions (and necrotic myocytes) at 6 d p.i, T2* blooming and hypointense T2 contrast is visible at 6 d p.i. as well, but the geometry of the patterns is more difficult to interpret (Fig 6B) in terms of paramagnetic inhomogeneities. This might be due to the small size of the lesions at this time of observation, or to a less paramagnetically altered environment.
In very good correlation to those observations, Prussian blue stainings were always positive at all stages of disease, but appeared less prominent in cardiac lesions early in infection and were generally much stronger at day 14 p.i. and at later stages of the disease.
Taken all together, the ex vivo MRI observations reveal that the source of hypointense contrast in gradient echo images is paramagnetic. This rules out calcification as a main source of T2* contrast, since calcification is expected to be diamagnetic and strongly support the pathophysiological hypothesis that iron deposits, which are paramagnetic, are the source of observed T2*w and T2 hypointense contrast.
Static magnetic field dependence
In Fig 7, the T2*w images of infected ABY/SnJ hearts with severe myocarditis are presented when measured at lower magnetic field strengths. The T2* hypointense contrast appeared much stronger at a very high magnetic field of 17.6T (Fig 7A and 7C) compared to a clinical magnetic field strength of 1.5T (Fig 7B and 7D). These observations are consistent with the hypothesis that iron deposits are the main source of T2/T2* contrast. Of translational interest is the observation that the T2*w contrast remained well observable ex vivo at 1.5T, suggesting that one will be able to diagnose in vivo CVB3-induced myocarditis in this animal model using human scanner.
In vivo T2* MRI study of acute and chronic myocarditis at high magnetic field strength of 7T and 17.6T
No adverse effect was observed during and after MRI investigations for all animals investigated. CVB3-infected mice with severe acute (Fig 8A3) or severe chronic (Fig 4A4 and 4B4) myocarditis were found to exhibit large hypointense regions within the myocardium in in vivo T2* weighted MRI (Fig 8A1 and Fig 4A1 and 4B1 and supplementary cine S3 and S4 Movies). In accordance with the previously presented ex vivo results, the location of the hypointense regions matches well with the lesions observed in histology. Accordingly, animals with a mild infection and a smaller extent of myocardial lesions (Fig 8B3) revealed fewer dark spots in T2* weighted images (Fig 8B1). In some hearts where only a few, very small lesions are present, MRI does not detect myocardial lesions. This can be explained by the higher sensitivity of histology which is capable to detect myocyte damage at the single cell level compared to MRI. Detailed results are presented in Tables 1 and 2. In vivo, a lesion specific T2* blooming effect was always observed as illustrated in Fig 8A1 (short TE, severe myocarditis) compared to A2 (long TE, severe myocarditis) and B1 (short TE, weak myocarditis) compared to B2 (long TE, weak myocarditis), demonstrating that local susceptibility inhomogeneities in vivo and ex vivo are the main cause of the observed contrast.
Table 2. Comparison of the MR / histology findings for all animals with disease 9dpi or later.
MR1 | MR2 | MR3 | |
---|---|---|---|
H1 | 7 | 0 | 0 |
H2 | 7 | 8 | 0 |
H3 | 0 | 0 | 13 |
The abbreviations MR1, MR2 and MR3 are used to designate the 3 defined MR groups: MR1 no myocarditis, MR2 mild myocarditis and MR3 severe myocarditis. The abbreviation H1, H2 and H3 are used to define the histological groups no myocarditis (H1, observed only in control animals), mild myocarditis (H2) and severe myocarditis (H3).
Visualization of inflammation using superparamagetic iron oxide nanoparticles
A further aim of our investigations was to evaluate whether cardiac inflammatory immune cells, especially macrophages, can be specifically detected by T2*contrast in CVB3-infected mice. For these experiments, we used different kinds of nanoparticles including the superparamagnetic iron oxide nanoparticles Feraheme™, revealing comparable results. Feraheme™ consists of ferumoxytol and was approved for iron replacement therapy in patients with anemia. This makes this MRI contrast agent [18,19] very attractive. ABY/SnJ mice were infected with CVB3 for 12 days and tail-injected with a 10mg Fe /kg ferumoxytol dosis. Animals were measured with MRI in vivo one hour prior ferumoxytol injection (Fig 9, top row, left image) and two days after (right image). It was interesting to realize that the hypointense T2* contrast of the severely inflamed myocardium did not significantly change before and after ferumoxytol injection.
A clearly enhanced ferumoxytol uptake by macrophages was found 2 days post contrast agent injection as demonstrated by Prussian blue staining (Fig 9, middle and bottom rows). However, so far it is unclear whether primarily ferumoxytol-containing macrophages or necrotic myocytes or both induce the hypointense contrast in T2*w images. Further MRI experiments are needed to investigate whether iron deposits in myocytes can be discriminated from induced iron storage in macrophages by this approach in order to provide a tool for the diagnosis of acute and chronic myocarditis.
Discussion
In this study, we have shown that T2* MRI imaging is capable to detect virus-induced inflammatory cardiac lesions in vivo and ex vivo in different mouse strains at a very high resolution. Our data demonstrate that T2*weighted imaging is a very sensitive and reliable technique to diagnose in vivo the severity of myocarditis induced by CVB3 infection at different stages of the disease.
Correlation of ex vivo gradient echo and spin echo images with histology revealed that the hypointense areas in MRI reflect tissue lesions becoming paramagnetic in the course of infection. Prussian blue staining illustrates that paramagnetic areas in the heart are due to iron deposits. From former investigations, we know that CVB3-infected hearts are characterized by iron deposits in infected cardiomyocytes and some macrophages resulting from altered iron metabolism from day 6 p.i. until late stages of myocarditis [13]. Iron deposition is known to be paramagnetic which was shown in numerous MRI investigations. In absence of other known pathophysiological events in this animal model causing strong local paramagnetism within cardiac lesions and in absence of microbleeds, it can be concluded that iron deposits are the cause for the MRI contrast as observed at any stage of the CVB3-induced disease in ABY/SnJ and SWR/J mouse strains.
The existence of paramagnetic iron overload within virus-induced tissue lesions in this murine myocarditis model explains the visualization of tissues with very high sensitivity using only T2*w imaging avoiding injections of contrast agents as commonly used in Late Gadolinium Enhancement (LGE) CMR experiments. This is a remarkable finding in CVB3-infected mice. Whether iron overload is also present in heart tissue lesions of patients with enteroviral myocarditis has to be determined. In addition, it would be interesting to investigate whether humans with viral myocarditis reveal different T2*w imaging than patients with e.g. non-infectious myocarditis.
To the best of our knowledge, no hypointense T2* contrast have been reported in humans with myocarditis yet. However, disturbances in iron metabolism might be associated with the involvement of inflammatory heart diseases). Recently, we reported a patient with iron overload in association of various cardiac virus infections (HHV6, EBV and PVB19) and inflammation [20]. So far, the interrelationships between iron, viral infections and immune reactions are not well studied. It is suggested that high iron concentrations might increase the susceptibility for infections by modifying the host immune response, specifically by impairment of cell-mediated immune mechanisms. E.g., increased loading of macrophages with iron was found to result in the inhibition of IFN-gamma-mediated pathways. In hepatitis B infection, it was described that patients with higher levels of serum iron or ferritin are less likely to achieve spontaneous recovery after acute HBV infection. It is also reported that excess iron enhances fibrogenic pathways and worsens the clinical course of HCV infection by causing oxidative stress. In addition, excess iron is capable to decrease the viability of HIV-infected cells and elevates the activity of reverse transcriptase, indicating that iron overload associated with HIV infection is detrimental to host cell responses against this infection [21]. More recently, we found that iron overload in the myocardium may potentiate the effects of enterovirus infection by the NO/HO-1 pathway, thus increasing cardiac pathogenicity by oxidative stress [13].
By electron microscopy iron deposits seem to be mainly located in structurally affected mitochondria of infected myocytes. This observation explains well the finding that the necrosis of myocytes in the course of CVB3 infection is associated with a diminished energy metabolism as suggested by Schulze et al. [22]. In their paper a tight correlation was described between a disturbed energy turnover and the cardiac performance in CVB3-infected ASW/SnJ mice, confirming the association of mitochondrial dysfunction with the pathophysiology of the disease. A close correlation between high cardiac CVB3 titers with cardiac mitochondrial dysfunction was demonstrated in susceptible ASW/SnJ mice during acute myocarditis [23]. Thus, the imbalanced energy levels due to disturbances in iron metabolism contribute to the severity of the enteroviral myocarditis in mice. Importantly, perturbations in energy metabolism has not only been demonstrated in murine but also in human enteroviral myocarditis [24], assuming that related processes might contribute to heart failure in chronic myocarditis.
The value of the study is limited by the absence of Gadolinium late enhancement imaging during acute and chronic myocarditis. LGE provides MR contrast related to fibrosis or lesion volume and it would be of great interest in the next study to compare both contrasts to get valuable insights into the interplay between the two different sources of contrast.
In the imaging community, there is much interest in visualizing inflammation processes in the heart by using MRI using cellular and molecular MR imaging strategies based on the administration and detection of contrast agents designed to induce local susceptibility artifacts and therefore hypointense T2* contrast. However, as shown in our study, such strategies might suffer from low sensitivity and reduced/complicated diagnostic value since it might become very difficult to differentiate between exogenous and endogenous magnetic susceptibility induced T2* signal losses. This is a severe problem enhanced by the fact that most probably the location of the targeted molecular events i.e. for the visualization of immune cells will correlate spatially with the cardiac lesions characterized by the endogenous T2* contrast. Furthermore, the endogenous T2* contrast allows in vivo to localize a lesion with good sensitivity, but the resolution dependent blooming nature of T2* contrast makes lesion appear bigger than they are in reality, increasing the possibility of image contrast interference between exogenous and endogenous T2*w contrast. To illustrate this problem, we reported on an experiment we have been conducted on the group of CVB3-infected animals measured in vivo at day 14 p.i. (Fig 9). In this experiment, the endogenous hypointense T2* contrast appeared rather unchanged two days after ferumoxytol injection, and it was not possible to spatially differentiate hypointense regions (Fig 9, top right) resulting from iron deposits in necrotic myocytes from labeled macrophages after uptake of iron-containing nanoparticles.
In future, it is feasible to think of using the strong R1-relaxivity properties of iron oxide contrast agents and try to implement ultra-short echo time based protocols to avoid the contrast interference between accumulated endogenous and extraneous paramagnetic substances. However, there is an additional physiological dilemma resulting from the administration of iron oxide contrast agents with pathological iron overload: the biodegradability of some iron oxide contrast agents like ferumoxytol can be very high, resulting in an increased plasma iron concentration. This high level of plasma iron might lead to further incorporation of iron in infected myocytes, resulting first in a potential increase of the endogenous T2* and second in a possible modulation of the pathology of affected myocytes subjected to iron overload. On the other hand, we have shown that high concentrations of ferumoxytol (40mg Fe) correlates with strong Prussian blue stainings (Fig 9), not only of necrotic myocytes but also for infiltrating macrophages, suggesting that inflammation might be visualized using ferumoxytol in this animal model. Further MRI investigations are needed to investigate whether it is possible to differentiate iron positive myocytes from infiltrating macrophages invading the heart during infection. Also, it will be important to see whether by this approach patients with infarction can be differentiated from patients with myocarditis. Yilmaz et al. [25] demonstrated that ultrasmall superparamagnetic iron oxide nanoparticles (USPIO) enable a more detailed characterization of myocardial pathology mainly by detecting infiltrating macrophages in patients with myocardial infarction.
A very promising alternative to imaging inflammation with iron oxide contrast agents in presence of local susceptibility inhomogeneity is given by 19F MRI. Ye et al. [26] have shown experimentally that 19F MRI can be a very robust MRI imaging technique in regions with strong susceptibility inhomogeneities. Recently, the experimental application of 19F MRI to image the infiltration of macrophages in the murine model of CVB3 myocarditis was presented [10,11].
Conclusion
In conclusion, we show in this study that iron deposition resulting from disturbed iron metabolism in necrotic myocytes of cardiac lesions of CVB3-infected mice results in a strong magnetic susceptibility difference between lesions and healthy myocardium which in turns results in strong T2* contrast in vivo and ex vivo. This MRI technique provides a fast and sensitive diagnostic tool to determine the severity of viral myocarditis and the precise localization of tissue damage without the use of any contrast agents in this model system.
Supporting information
Acknowledgments
We gratefully acknowledge Philipp Kagerbauer, and Sabine Voll for animal care and technical assistance.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
This work was financially supported by a grant from the German Federal Ministry of Education and Research (BMBF; grant-ID 01EZ0818 and 13EZ0817), and in part by the Deutsche Herzstiftung e.V. (Ye, Y-X).
References
- 1.Cooper LT. Myocarditis. N Engl J Med. 2009;360: 1526–1538. 10.1056/NEJMra0800028 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pankuweit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev. 2013;18: 683–702. 10.1007/s10741-012-9357-4 [DOI] [PubMed] [Google Scholar]
- 3.Sagar S, Liu PP, Cooper LT. Myocarditis. Lancet Lond Engl. 2012;379: 738–747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34: 2636–2648, 2648a–2648d. 10.1093/eurheartj/eht210 [DOI] [PubMed] [Google Scholar]
- 5.Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59: 779–792. 10.1016/j.jacc.2011.09.074 [DOI] [PubMed] [Google Scholar]
- 6.Moon JC. What Is Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy? Rev Esp Cardiol Engl Ed. 2007;60: 1–4. [PubMed] [Google Scholar]
- 7.Gruhle S, Sauter M, Szalay G, Ettischer N, Kandolf R, Klingel K. The prostacyclin agonist iloprost aggravates fibrosis and enhances viral replication in enteroviral myocarditis by modulation of ERK signaling and increase of iNOS expression. Basic Res Cardiol. 2012;107: 287 10.1007/s00395-012-0287-z [DOI] [PubMed] [Google Scholar]
- 8.Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A. 1992;89: 314–318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Brunner S, Todica A, Böning G, Nekolla SG, Wildgruber M, Lehner S, et al. Left ventricular functional assessment in murine models of ischemic and dilated cardiomyopathy using [18 F]FDG-PET: comparison with cardiac MRI and monitoring erythropoietin therapy. EJNMMI Res. 2012;2: 43 10.1186/2191-219X-2-43 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jacoby C, Borg N, Heusch P, Sauter M, Bönner F, Kandolf R, et al. Visualization of immune cell infiltration in experimental viral myocarditis by 19F MRI in vivo. Magn Reson Mater Phys Biol Med. 2014;27: 101–106. [DOI] [PubMed] [Google Scholar]
- 11.Ye Y, Helluy X, Sauter M, Basse-Luesebrink TC, Kampf T, Hiller K-H, et al. Visualization of Inflammation and Characterization of Lesions in Viral Myocarditis Mouse Model by Combined 19F-MR Cell Tracking and 1H Cardiac MRI. Circulation. Lippincott Williams & Wilkins 530 Walnut St, Philadelphia, Pa 19106–3621 USA; 2012. [Google Scholar]
- 12.Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, et al. Osteopontin A Fibrosis-Related Marker Molecule in Cardiac Remodeling of Enterovirus Myocarditis in the Susceptible Host. Circ Res. 2009;104: 851–859. 10.1161/CIRCRESAHA.109.193805 [DOI] [PubMed] [Google Scholar]
- 13.Ursu ON, Sauter M, Ettischer N, Kandolf R, Klingel K. Heme Oxygenase-1 Mediates Oxidative Stress and Apoptosis in Coxsackievirus B3-Induced Myocarditis. Cell Physiol Biochem. 2014;33: 52–66. 10.1159/000356649 [DOI] [PubMed] [Google Scholar]
- 14.Grant SC, Murphy LA, Magin RL, Friedman G. Analysis of multilayer radio frequency microcoils for nuclear magnetic resonance spectroscopy. IEEE Trans Magn. 2001;37: 2989–2998. [Google Scholar]
- 15.Reichenbach JR, Haacke EM. Introduction to Susceptibility Weighted Imaging In: Haacke E rk, Reichenbach JR, editors. Susceptibility Weighted Imaging in MRI. John Wiley & Sons, Inc.; 2011. pp. 1–16. [Google Scholar]
- 16.Posse S, Aue WP. Susceptibility artifacts in spin-echo and gradient-echo imaging. J Magn Reson 1969. 1990;88: 473–492. [Google Scholar]
- 17.Schenck JF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys. 1996;23: 815–850. 10.1118/1.597854 [DOI] [PubMed] [Google Scholar]
- 18.Thorek DLJ, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging. Ann Biomed Eng. 2006;34: 23–38. 10.1007/s10439-005-9002-7 [DOI] [PubMed] [Google Scholar]
- 19.Weinstein JS, Varallyay CG, Dosa E, Gahramanov S, Hamilton B, Rooney WD, et al. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab. 2009;30: 15–35. 10.1038/jcbfm.2009.192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Klingel K. The image of the month: Association of iron overload with cardiac virus infectio [Internet]. 2014 [cited 23 Nov 2015]. Available: http://www.escardio.org/Guidelines-&-Education/E-learning/Clinical-cases/Myocardial-and-pericardial-diseases/The-image-of-the-month-Association-of-iron-overload-with-cardiac-virus-infectio
- 21.Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: expanding spectrum. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2007;11: 482–487. [DOI] [PubMed] [Google Scholar]
- 22.Schulze K, Witzenbichler B, Christmann C, Schultheiss HP. Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Cardiovasc Res. 1999;44: 91–100. [DOI] [PubMed] [Google Scholar]
- 23.Ebermann L, Wika S, Klumpe I, Hammer E, Klingel K, Lassner D, et al. The mitochondrial respiratory chain has a critical role in the antiviral process in Coxsackievirus B3-induced myocarditis. Lab Investig J Tech Methods Pathol. 2012;92: 125–134. [DOI] [PubMed] [Google Scholar]
- 24.Dörner A, Pauschinger M, Schwimmbeck PL, Kühl U, Schultheiss HP. The shift in the myocardial adenine nucleotide translocator isoform expression pattern is associated with an enteroviral infection in the absence of an active T-cell dependent immune response in human inflammatory heart disease. J Am Coll Cardiol. 2000;35: 1778–1784. [DOI] [PubMed] [Google Scholar]
- 25.Yilmaz A, Dengler MA, van der Kuip H, Yildiz H, Rösch S, Klumpp S, et al. Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach. Eur Heart J. 2013;34: 462–475. 10.1093/eurheartj/ehs366 [DOI] [PubMed] [Google Scholar]
- 26.Ye YX, Basse-Lüsebrink TC, Arias-Loza PA, Kocoski V, Kampf T, Gan Q, Bauer E, Sparka S, Helluy X, Hu K, Hiller KH, Boivin-Jahns V, Jakob PM, Jahns R, Bauer WR. Monitoring of monocyte recruitment in reperfused myocardial infarction with intramyocardial hemorrhage and microvascular obstruction by combined fluorine 19 and proton cardiac magnetic resonance imaging. Circulation. 2013. October 22;128(17):1878–88. 10.1161/CIRCULATIONAHA.113.000731 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.